155 related articles for article (PubMed ID: 12878247)
21. The efficacy of transrectal ultrasound and prostate cancer.
Mandell MJ; Hopper KD; Jarowenko MV; Rohner TJ; Belis JA; Stryker JA; Meilstrup JW; Thieme GA
Crit Rev Diagn Imaging; 1991; 32(4):273-300. PubMed ID: 1958294
[TBL] [Abstract][Full Text] [Related]
22. 3D prostate elastography: algorithm, simulations and experiments.
Patil AV; Garson CD; Hossack JA
Phys Med Biol; 2007 Jun; 52(12):3643-63. PubMed ID: 17664564
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
[TBL] [Abstract][Full Text] [Related]
24. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
25. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
[TBL] [Abstract][Full Text] [Related]
26. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).
Biermann K; Montironi R; Lopez-Beltran A; Zhang S; Cheng L
Prostate; 2010 Aug; 70(11):1196-200. PubMed ID: 20564422
[TBL] [Abstract][Full Text] [Related]
27. [Local recurrence of prostate cancer after curative therapy. HIFU (Ablatherm) as a treatment option].
Chaussy C; Thüroff S; Bergsdorf T
Urologe A; 2006 Oct; 45(10):1271-5. PubMed ID: 17006697
[TBL] [Abstract][Full Text] [Related]
28. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report.
Uchida T; Sanghvi NT; Gardner TA; Koch MO; Ishii D; Minei S; Satoh T; Hyodo T; Irie A; Baba S
Urology; 2002 Mar; 59(3):394-8; discussion 398-9. PubMed ID: 11880077
[TBL] [Abstract][Full Text] [Related]
29. [Bloodless prostate treatment using high-intensity focused ultrasound (HIFU)].
Eberle J; Böhlen D; Fügen M; Studer UE
Schweiz Med Wochenschr; 1996 Aug; 126(33):1385-92. PubMed ID: 8830396
[TBL] [Abstract][Full Text] [Related]
30. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue.
Ryan P; Finelli A; Lawrentschuk N; Fleshner N; Sweet J; Cheung C; van der Kwast T; Evans A
J Clin Pathol; 2012 Aug; 65(8):729-34. PubMed ID: 22659332
[TBL] [Abstract][Full Text] [Related]
31. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
32. New integrated imaging high intensity focused ultrasound probe for transrectal prostate cancer treatment.
Pichardo S; Gelet A; Curiel L; Chesnais S; Chapelon JY
Ultrasound Med Biol; 2008 Jul; 34(7):1105-16. PubMed ID: 18258351
[TBL] [Abstract][Full Text] [Related]
33. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
[TBL] [Abstract][Full Text] [Related]
34. MR imaging of prostate after treatment with high-intensity focused ultrasound.
Kirkham AP; Emberton M; Hoh IM; Illing RO; Freeman AA; Allen C
Radiology; 2008 Mar; 246(3):833-44. PubMed ID: 18223121
[TBL] [Abstract][Full Text] [Related]
35. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
[TBL] [Abstract][Full Text] [Related]
36. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
[TBL] [Abstract][Full Text] [Related]
37. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
38. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
Uchida T; Illing RO; Cathcart PJ; Emberton M
BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
[TBL] [Abstract][Full Text] [Related]
39. The contribution of strain patterns in characterization of prostate peripheral zone lesions at transrectal ultrasonography.
Zhang Y; Tang J; Li YM; Fei X; He EH; Li QY; Shi HY
Acta Radiol; 2012 Feb; 53(1):119-26. PubMed ID: 22139716
[TBL] [Abstract][Full Text] [Related]
40. Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions.
Hamper UM; Sheth S; Walsh PC; Holtz PM; Epstein JI
Radiology; 1991 Jul; 180(1):101-4. PubMed ID: 2052673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
